{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-098131","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2025-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.123822+00:00","generated_at":"2026-05-17T04:06:33.357462+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"60 Degrees Pharma shareholders approve reverse split, equity plan amendment at annual meeting","bullets":["Five directors elected: Geoffrey Dow, Charles Allen, Cheryl Xu, Stephen Toovey, Paul Field.","Amendment to 2022 Equity Incentive Plan approved, increasing available shares by 250,000.","Reverse stock split authorized at ratio ranging from 1:3 to 1:10, as determined by the Board.","Ratification of RBSM LLP as independent registered public accounting firm for FY2025.","Adjournment proposal approved; quorum of ~40% of outstanding shares was present."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-098131","json":"https://secwatch.observer/filing/0001213900-25-098131.json","markdown":"https://secwatch.observer/filing/0001213900-25-098131.md","text":"https://secwatch.observer/filing/0001213900-25-098131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025098131/0001213900-25-098131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025098131/ea0260878-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:06:33.357462+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}